Approximately 900 children/adolescents are treated with radiotherapy (RT) every year in France. However, among the 80% of survivors, the cumulative incidence of long-term morbidity – including second malignancies - reach thirty years after the cancer diagnosis. | Validation of a high performance functional assay for individual radiosensitivity in pediatric oncology A prospective cohort study ARPEGE